Envoy Medical (COCH) Convertible Debt (2022 - 2023)
Envoy Medical (COCH) posted Convertible Debt of $2.5 million for Q4 2023, down 37.5% sequentially from $4.0 million in Q3 2023, and down 92.51% YoY from $33.4 million in Q4 2022.
Envoy Medical (COCH) Convertible Debt (2022 - 2023) Analysis & Trends
Envoy Medical has reported Convertible Debt for 2 years, with the latest figure at $2.5 million in Q4 2023.
- Quarterly Convertible Debt fell 92.51% year-over-year to $2.5 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $2.5 million (down 92.51% YoY) and the FY2023 annual result came in at $2.5 million, down 92.51% from the prior year.
- Convertible Debt eased to $2.5 million in Q4 2023 per COCH's latest filing, from $4.0 million in the prior quarter.
- Over five years, Convertible Debt peaked at $33.4 million in Q4 2022 and troughed at $2.5 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | Envoy Medical | 77.89 Mn | 58.22 Mn | -227,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2.50 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 14.60 Mn |
| Dec 31, 2022 | 33.40 Mn |